Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)

v3.22.2.2
BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2022
CAD ($)
Disclosure of detailed information about biological assets [abstract]  
Beginning Balance $ 1,687
Production costs capitalized 4,867
Changes in fair value less cost to sell due to biological transformation 1,200
Transferred to inventory upon harvest (6,152)
Restructuring write-off (108)
Foreign exchange translation (3)
Ending Balance $ 1,491